{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:36:56Z","timestamp":1792521416067,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.rmed.2026.108649","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T17:00:50Z","timestamp":1768237250000},"page":"108649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploring the relationship between adherence and outcomes in pulmonary arterial hypertension: A retrospective cohort study in the United States"],"prefix":"10.1016","volume":"252","author":[{"given":"Teresa","family":"De Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly J.","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0035-6301","authenticated-orcid":false,"given":"Hayley D.","family":"Germack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5017-1834","authenticated-orcid":false,"given":"Nicole S.","family":"Croteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6141-8043","authenticated-orcid":false,"given":"Jason C.","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurinderpal","family":"Doad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Panjabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-7902","authenticated-orcid":false,"given":"Harrison","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.rmed.2026.108649_bib1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.rmed.2026.108649_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018816294","article-title":"Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database","volume":"9","author":"Studer","year":"2019","journal-title":"Pulm. Circ."},{"issue":"1","key":"10.1016\/j.rmed.2026.108649_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020977300","article-title":"Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review","volume":"11","author":"Leber","year":"2021","journal-title":"Pulm. Circ."},{"issue":"1","key":"10.1016\/j.rmed.2026.108649_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.10-1166","article-title":"Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL registry","volume":"140","author":"Brown","year":"2011","journal-title":"Chest"},{"issue":"173","key":"10.1016\/j.rmed.2026.108649_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0006-2024","article-title":"Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review","volume":"33","author":"Le Bozec","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2026.108649_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019880086","article-title":"3rd, Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists or phosphodiesterase type-5 inhibitors","volume":"10","author":"Frantz","year":"2020","journal-title":"Pulm. Circ."},{"issue":"1","key":"10.1016\/j.rmed.2026.108649_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40256-022-00553-6","article-title":"Adherence and discontinuation of disease-specific therapies for pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"23","author":"Qadus","year":"2022","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"1","key":"10.1016\/j.rmed.2026.108649_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.36469\/jheor.2024.91396","article-title":"Effectiveness of single-tablet combination therapy in improving adherence and persistence and the relation to clinical and economic outcomes","volume":"11","author":"Paoli","year":"2024","journal-title":"J Health Econ Outcomes Res"},{"issue":"12","key":"10.1016\/j.rmed.2026.108649_bib9","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1111\/bcp.14347","article-title":"Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects","volume":"86","author":"Grill","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.rmed.2026.108649_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.846","article-title":"Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: adaptive design in the COVID-19 pandemic","volume":"9","author":"Csonka","year":"2021","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"10.1016\/j.rmed.2026.108649_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacc.2023.10.045","article-title":"Randomized trial of macitentan\/tadalafil single-tablet combination therapy for pulmonary arterial hypertension","volume":"83","author":"Gr\u00fcnig","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.rmed.2026.108649_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12441","article-title":"Practices affEcting macitentan and selexipag patient persistence rates utilizing pulmonary arterial hypertension clinical Site and patIent perSpecTives (PERSIST): a US qualitative analysis","volume":"14","author":"Shlobin","year":"2024","journal-title":"Pulm. Circ."},{"issue":"4","key":"10.1016\/j.rmed.2026.108649_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01180-2024","article-title":"Management of pulmonary hypertension in special conditions","volume":"64","author":"Preston","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.108649_bib15","series-title":"Current Population Survey, 1960 to 2024 Annual Social and Economic Supplements (CPS ASEC), Table 21","year":"2024"},{"key":"10.1016\/j.rmed.2026.108649_bib16","series-title":"A Language and Environment for Statistical Computing","year":"2022"},{"issue":"4","key":"10.1016\/j.rmed.2026.108649_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174426","article-title":"Computation of adherence to medication and visualization of medication histories in R with AdhereR: towards transparent and reproducible use of electronic healthcare data","volume":"12","author":"Dima","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2026.108649_bib18","series-title":"Adherer: Computation and Visualisation of Adherence to Medications from Electronic Healthcare Data","author":"Dediu","year":"2024"},{"key":"10.1016\/j.rmed.2026.108649_bib19","series-title":"Modeling Survival Data : Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.rmed.2026.108649_bib20","series-title":"A Package for Survival Analysis in R","author":"Therneau","year":"2023"},{"issue":"2","key":"10.1016\/j.rmed.2026.108649_bib21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.36469\/9812","article-title":"Using real world evidence to describe pulmonary arterial hypertension treatment patterns, healthcare resource utilization, and costs associated with PDE-5 inhibitor monotherapy","volume":"5","author":"Ruiz","year":"2018","journal-title":"J Health Econ Outcomes Res"},{"issue":"3","key":"10.1016\/j.rmed.2026.108649_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40801-020-00183-x","article-title":"Medication adherence and healthcare costs among patients with pulmonary arterial hypertension treated with oral prostacyclins: a retrospective cohort study","volume":"7","author":"Dean","year":"2020","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.rmed.2026.108649_bib23","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fphar.2018.01290","article-title":"A systematic review of medication adherence thresholds dependent of clinical outcomes","volume":"9","author":"Baumgartner","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.rmed.2026.108649_bib24","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/pds.4334","article-title":"The myths of medication adherence","volume":"26","author":"Gellad","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.rmed.2026.108649_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/2045893217743616","article-title":"Medication and patient factors associated with adherence to pulmonary hypertension targeted therapies","volume":"8","author":"Grady","year":"2018","journal-title":"Pulm. Circ."},{"issue":"6","key":"10.1016\/j.rmed.2026.108649_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/osp4.450","article-title":"Validated methods for identifying individuals with obesity in health care administrative databases: a systematic review","volume":"6","author":"Samadoulougou","year":"2020","journal-title":"Obes Sci Pract"},{"issue":"22","key":"10.1016\/j.rmed.2026.108649_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026620","article-title":"Association between copayment and adherence to medications for pulmonary arterial hypertension","volume":"11","author":"Schikowski","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.rmed.2026.108649_bib28","article-title":"Adherence and treatment patterns of disease-specific drugs among patients with pulmonary arterial hypertension: a nationwide, new-user cohort study","volume":"13","author":"Tsai","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112600017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112600017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:40:44Z","timestamp":1775306444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461112600017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"alternative-id":["S095461112600017X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108649","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the relationship between adherence and outcomes in pulmonary arterial hypertension: A retrospective cohort study in the United States","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108649"}}